Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors

DSpace/Manakin Repository

Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors

Citable link to this page

 

 
Title: Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
Author: Chang, ZeNan L.; Silver, Pamela A.; Chen, Yvonne Y.

Note: Order does not necessarily reflect citation order of authors.

Citation: Chang, ZeNan L., Pamela A. Silver, and Yvonne Y. Chen. 2015. “Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors.” Journal of Translational Medicine 13 (1): 161. doi:10.1186/s12967-015-0519-8. http://dx.doi.org/10.1186/s12967-015-0519-8.
Full Text & Related Files:
Abstract: Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer therapy, particularly in the treatment of B-cell malignancies. However, optimization of CAR-T cell production remains a trial-and-error exercise due to a lack of phenotypic benchmarks that are clearly predictive of anti-tumor functionality. A close examination of the dynamic changes experienced by CAR-T cells upon stimulation can improve understanding of CAR–T-cell biology and identify potential points for optimization in the production of highly functional T cells. Methods: Primary human T cells expressing a second-generation, anti-CD19 CAR were systematically examined for changes in phenotypic and functional responses to antigen exposure over time. Multi-color flow cytometry was performed to quantify dynamic changes in CAR-T cell viability, proliferation, as well as expression of various activation and exhaustion markers in response to varied antigen stimulation conditions. Results: Stimulated CAR-T cells consistently bifurcate into two distinct subpopulations, only one of which (CARhi/CD25+) exhibit anti-tumor functions. The use of central memory T cells as the starting population and the resilience—but not antigen density—of antigen-presenting cells used to expand CAR-T cells were identified as critical parameters that augment the production of functionally superior T cells. We further demonstrate that the CARhi/CD25+ subpopulation upregulates PD-1 but is resistant to PD-L1-induced dysfunction. Conclusions: CAR-T cells expanded ex vivo for adoptive T-cell therapy undergo dynamic phenotypic changes during the expansion process and result in two distinct populations with dramatically different functional capacities. Significant and sustained CD25 and CAR expression upregulation is predictive of robust anti-tumor functionality in antigen-stimulated T cells, despite their correlation with persistent PD-1 upregulation. The functionally superior subpopulation can be selectively augmented by careful calibration of antigen stimulation and the enrichment of central memory T-cell type. Electronic supplementary material The online version of this article (doi:10.1186/s12967-015-0519-8) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1186/s12967-015-0519-8
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457995/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295689
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters